Skip to content

NEMAURA MEDICAL INC.

CIK 0001602078

← back to feed
Revenue (TTM)
$77.04K
−84.7% YoY Q3 Feb 2024
Net Income (TTM)
−$7.68M
−1.9% YoY Q3 Feb 2024
EPS Diluted (TTM)
−$0.28
+3.4% YoY Q3 Feb 2024
Gross Margin
2.2%
Q3 Feb 2024
Operating Margin
-9,150.4%
Q3 Feb 2024
Net Margin
-9,974.0%
Q3 Feb 2024
Free Cash Flow (TTM)
−$7.81M
Q3 Feb 2024
Cash
$137.42K
Q3 Feb 2024
Total Debt
$19.64M
Q3 Feb 2024
Shares Outstanding
28.9M sh
Q3 Feb 2024

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings